alphaGalCer-RBD
T74326
Overview
- SupplierTargetMol Chemicals
- Product NamealphaGalCer-RBD
- Delivery Days Customer999
- Category SupplierChemical
- CertificationResearch Use Only
- Chemical NamealfaGalCer-RBD
- Molecular FormulaC60H118N4O14
- Molecular Weight1119.6
- Scientific DescriptionalphaGalCer-RBD, a conjugate of the potent invariant natural killer T cell (iNKT) agonist alpha-Galactosylceramide (alphaGalCer) and the receptor-binding domain (RBD), serves as a self-adjuvanting lipoprotein that exhibits strong potential as a COVID-19 vaccine candidate. This compound effectively induces immunity against SARS-CoV-2 and its variants of concern by promoting the development of RBD-specific, cytokine-producing T cells.
- Shelf life instruction3 years
- Storage Instruction-20°C
- UNSPSC12352200